ArticleRadiology advances2026
Deep learning-based prediction of acute pancreatitis severity from abdominal CT with multicenter external validation.
Article in Radiology advances, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
28 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Acute pancreatitis (AP) is a common gastrointestinal disease with a rising global incidence. While most cases are mild, severe AP (SAP) carries high mortality. Early and accurate severity prediction facilitates management optimization. However, existing clinical severity prediction models, such as Bedside Index of Severity in Acute Pancreatitis (BISAP) and Modified CT Severity Index (mCTSI), have modest accuracy and often rely on data unavailable at admission. Purpose: This study proposes a deep learning (DL) model to predict AP severity using abdominal contrast-enhanced CT scans acquired within 24 hours of admission. Materials and Methods: We collected 10 130 studies from 8335 patients across a multi-site U.S. health system and 3488 studies from public datasets. The DL model was trained in 2 stages: (1) self-supervised pretraining on 11 896 unlabeled studies and (2) fine-tuning on 550 labeled studies. Performance was evaluated against mCTSI on a hold-out internal test set ( Results: On the internal test set, the model achieved areas under receiver operating curve (AUROCs) of 0.888 (95% CI: 0.800-0.960, sensitivity 0.50, specificity 0.92) for SAP and 0.888 (95% CI: 0.819-0.946, sensitivity 0.75, specificity 0.85) for mild AP (MAP), outperforming mCTSI ( Conclusion: The proposed DL model achieved performance comparable to or better than established prognostic tools and maintained robust external performance. These findings suggest that AI-assisted CT analysis may support early, automated risk stratification of AP.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.